Log in  First Connection?

Kidney TransplantationArchives

Clinical Impact and Cost-effectiveness of Everolimus Combination Therapy in Liver Transplant Recipients: Focus on the Risk of Cancer, Infection, and Renal Function.

 Published on 29/07/2026 |  Original article (Full-text)  | Jang, Suk-Chan PharmD, PhD et al. | Transplantation. Volume 110(7).

Post-liver transplant complications-cancer, infections, and renal dysfunction-impose substantial clinical and economic impact on recipients. This study evaluated clinical impacts and cost-effectiveness of adding everolimus (EVR) to a calcineurin inhibitor (CNI)-based regimen in liver transplant recipients,...

Kidney biopsy analysis of 14 cases of renal disease after unrelated cord blood transplantation

 Published on 22/07/2026 |  Original article (Full-text)  | Mizuta, Masato et al. | BMC Nephrology. Volume 27(1).

To evaluate kidney biopsy findings to clarify renal disease in patients after hematopoietic stem cell transplantation (HSCT) using unrelated umbilical cord blood transplantation (UCBT). Methods: We retrospectively examined 14 patients who underwent UCBT at Toranomon Hospital, Tokyo, Japan, from 2015...

Urologic malignancy in renal transplant recipients: Analysis of OPTN/UNOS data from 2000 to 2022

 Published on 15/07/2026 |  Original article (Full-text)  | Hao, Xiaowei et al. | BMC Cancer. Volume 26(1).

The increasing incidence of urologic malignancy after renal transplantation (RT) has become a leading cause of recipient mortality. However, no recent analyses have been performed to identify the risk factors for post-transplant urologic malignancy (PTUM) and to evaluate the effect of PTUM on RT outcomes. Materials...